City State Bank’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-50
Closed -$1K 741
2024
Q1
$1K Hold
50
﹤0.01% 680
2023
Q4
$1K Hold
50
﹤0.01% 648
2023
Q3
$1K Hold
50
﹤0.01% 658
2023
Q2
$2K Hold
50
﹤0.01% 636
2023
Q1
$2K Hold
50
﹤0.01% 625
2022
Q4
$1K Hold
50
﹤0.01% 628
2022
Q3
$2K Hold
50
﹤0.01% 599
2022
Q2
$3K Hold
50
﹤0.01% 573
2022
Q1
$3K Hold
50
﹤0.01% 595
2021
Q4
$5K Buy
+50
New +$4.39K ﹤0.01% 548

Other funds holding FLGT

City State Bank's FLGT Position: Q2 2024 in Review

City State Bank sold out of Fulgent Genetics (FLGT) in Q2 2024, closing a stake of 50 shares — an estimated $1K sold.

City State Bank first reported a position in FLGT in Q4 2021 and held it in 10 quarters. The position peaked at $5K in Q4 2021. 173 funds tracked by Wall St. Rank hold FLGT as of Q2 2024.

  • City State Bank reported no remaining Fulgent Genetics position as of Q2 2024 after selling out during the quarter.
  • City State Bank sold 50 Fulgent Genetics shares in Q2 2024, an estimated $1K.
  • City State Bank first reported a position in Fulgent Genetics in Q4 2021 and held it in 10 quarters.
  • City State Bank's Fulgent Genetics position peaked at $5K in Q4 2021.
  • 173 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2024.

Based on City State Bank's 13F filing for Q2 2024, filed 8 Jul 2024.